Abbott Quarterly Results for Trading Insights

ABBOTINDIA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,414 Cr
QMarch 2025
Quarterly Results

Abbott Quarterly Results Key Highlights

  • Revenue of ₹6,685 Cr in March 2025 (+0.0% vs March 2025, +9.6% vs March 2024)
  • Net Profit of ₹1,414 Cr in March 2025 (+0.0% vs March 2025, +17.7% vs March 2024)
  • EBITDA of ₹1,970 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 26.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹665.62 in March 2025 (+0.0% vs March 2025)

Abbott Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 7,113 6,685 6,097 5,503 4,997 6.4% -
Net Profit (₹ Cr) 1,524 1,414 1,201 949 799 - -
EBITDA (₹ Cr) 2,128 1,970 1,701 1,360 1,165 - -
EPS (₹) 717.20 665.62 565.28 446.80 375.87 - -
Operating Margin (%) 27.0% 26.0% 25.0% 23.0% 22.0% - -

Abbott Share Price Trend Around Quarterly Results

Visualize Abbott's 1-year price movement across quarterly results — ideal for logging trades in Abbott share price chart using Tickjournal. All values in ₹.

Related Pages for Abbott

Additional stock information and data for ABBOTINDIA

ABBOTINDIA quarterly financials
ABBOTINDIA book value
ABBOTINDIA intrinsic value calculation
Abbott 52-week
Abbott market worth
ABBOTINDIA share price history
ABBOTINDIA shareholding pattern

Profitability Ratios

Profit Margin 21.2%
EBITDA Margin 29.5%
Operating Margin 26.0%
ROE (Annual) 33.4%

Balance Sheet Highlights

Total Assets ₹5,917 Cr
Total Equity ₹4,233 Cr
Current Assets ₹4,742 Cr
Current Liabilities ₹277 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,012 Cr
Investing Cash Flow ₹182 Cr
Financing Cash Flow ₹-925 Cr
Net Cash Flow ₹269 Cr

Current Market Data

Current Price ₹26960.00
Exchange NSE
Last Updated Mar 13, 2026

Revenue Trend (₹ Cr)

March 2023 5,503
March 2024 6,097
March 2025 6,685
2026 7,113

Net Profit Trend (₹ Cr)

March 2023 949
March 2024 1,201
March 2025 1,414
2026 1,524

Operating Margin Trend (%)

March 2023 23.0%
March 2024 25.0%
March 2025 26.0%
2026 27.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Abbott quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹438,094.57 Cr 1801.6 14,875 3,125 +10.8% - 21.0% 138.6
Divis Laboratories
Sept 2025 		₹167,616.86 Cr 6071.0 2,860 689 +7.1% - 24.1% 233.8
Torrent Pharmaceuti…
Sept 2025 		₹148,025.88 Cr 4390.0 3,219 591 +11.3% - 18.4% 250.3
Dr Reddys Laborator…
Sept 2025 		₹110,630.25 Cr 1292.3 9,135 1,337 +1.1% - 14.6% 79.9
Cipla
Sept 2025 		₹107,029.80 Cr 1314.7 7,716 1,353 +12.0% - 17.5% 78.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores